Prediction of severe immune-related adverse events requiring hospital admission in patients on immune checkpoint inhibitors: study of a population level insurance claims database from the USA

Background Immune-related adverse events (irAEs) are a serious side effect of immune checkpoint inhibitor (ICI) therapy for patients with advanced cancer. Currently, predisposing risk factors are undefined but understanding which patients are at increased risk for irAEs severe enough to require hosp...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Kun-Hsing Yu, Shannon Wongvibulsin, William Murphy, Leyre Zubiri, Vartan Pahalyants, Mark Kalinich, Feicheng Wang, Vivek Naranbhai, Alexander Gusev, Chenyue Lu, Shawn G Kwatra, Yevgeniy R Semenov
Format: article
Langue:EN
Publié: BMJ Publishing Group 2021
Sujets:
Accès en ligne:https://doaj.org/article/a4140872710d449cbfe5498337fb0343
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!